Four weeks of near-normalization of blood glucose restores the insulin response to GIP and improves the insulin response to GLP-1 in patients with type 2 diabetes

被引：0
|
作者：
Hojberg, Patricia V.
Vilsbol, Tina
Knop, Filip K.
Bache, Michael
Madsbad, Sten
Krarup, Thure
Holst, Jens J.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [31] Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes
    Torekov, S. S.
    Kipnes, M. S.
    Harley, R. E.
    Holst, J. J.
    Ehlers, M. R.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 639 - 643
  • [32] TIRZEPATIDE, A DUAL GIP AND GLP-1 RECEPTOR AGONIST, INCREASES INSULIN SENSITIVITY AND IMPROVES PANCREATIC BETA-CELL FUNCTION IN TYPE 2 DIABETES
    Pirro, V.
    Nikooienejad, A.
    Lin, Y.
    Willency, J.
    Wilson, J.
    Duffin, K.
    Robins, D.
    Milicevic, Z.
    Haupt, A.
    Thomas, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A165 - A165
  • [33] Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetes
    Landersdorfer, Cornelia B.
    He, Yan-Ling
    Jusko, William J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (03) : 373 - 390
  • [34] The incretin hormones GIP and GLP-1 in healthy volunteers: Effects on gastric emptying rate and insulin response
    Edholm, T
    Gryback, P
    Lundberg, S
    Schmidt, PT
    Jacobsson, H
    Hellstrom, PM
    GASTROENTEROLOGY, 2005, 128 (04) : A608 - A608
  • [35] Effect of 4 weeks of hear-normalization of blood glucose on beta-cell sensitivity to glucose and GLP-1 in type 2 diabetic patients
    Hojberg, PV
    Zander, M
    Vilsboll, T
    Knop, FK
    Krarup, T
    Holst, JJ
    Madsbad, S
    DIABETOLOGIA, 2005, 48 : A201 - A201
  • [36] Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats
    Valverde, I
    Wang, GS
    Burghardt, K
    Kauri, LM
    Redondo, A
    Acitores, A
    Villanueva-Peñacarrillo, ML
    Courtois, P
    Sener, A
    Cancelas, J
    Malaisse, WJ
    Scott, FW
    ENDOCRINE, 2004, 23 (01) : 77 - 84
  • [37] Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats
    Isabel Valverde
    Gen-Sheng Wang
    Karolina Burghardt
    Lisa M. Kauri
    Araceli Redondo
    Alicia Acitores
    Maria L. Villanueva-Peñacarrillo
    Philippe Courtois
    Abdullah Sener
    Jesús Cancelas
    Willy J. Malaisse
    Fraser W. Scott
    Endocrine, 2004, 23 : 77 - 84
  • [38] Elevated early GLP-1 and increased overall GIP response in type 2 diabetes as compared to the general population
    Alssema, M.
    Rijkelijkhuizen, J. M.
    Holst, J. J.
    Eekhoff, E. M. W.
    't Hart, L. M.
    Nijpels, G.
    Dekker, J. M.
    DIABETOLOGIA, 2011, 54 : S218 - S218
  • [39] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [40] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
12345